<?xml version="1.0" encoding="UTF-8"?><rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:wfw="http://wellformedweb.org/CommentAPI/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>

<channel>
	<title>IT &amp; Data Management - Pharma Information Technology</title>
	<atom:link href="https://www.worldpharmatoday.com/it-data-management/feed/" rel="self" type="application/rss+xml" />
	<link>https://www.worldpharmatoday.com</link>
	<description>Magazine for the C-level Pharma Executives</description>
	<lastBuildDate>Tue, 31 Mar 2026 06:32:49 +0000</lastBuildDate>
	<language>en-US</language>
	<sy:updatePeriod>
	hourly	</sy:updatePeriod>
	<sy:updateFrequency>
	1	</sy:updateFrequency>
	<generator>https://wordpress.org/?v=6.9.4</generator>

<image>
	<url>https://www.worldpharmatoday.com/wp-content/uploads/2025/12/cropped-World-Pharma-Today-fevicon-32x32.jpg</url>
	<title>IT &amp; Data Management - Pharma Information Technology</title>
	<link>https://www.worldpharmatoday.com</link>
	<width>32</width>
	<height>32</height>
</image> 
	<item>
		<title>Smart Inspection Systems with HV Leak Detection Technology</title>
		<link>https://www.worldpharmatoday.com/production-manufacturing/smart-inspection-systems-with-hv-leak-detection-technology/</link>
		
		<dc:creator><![CDATA[Yuvraj]]></dc:creator>
		<pubDate>Tue, 31 Mar 2026 06:32:49 +0000</pubDate>
				<category><![CDATA[IT & Data Management]]></category>
		<category><![CDATA[Production & Manufacturing]]></category>
		<category><![CDATA[Techno Trends]]></category>
		<guid isPermaLink="false">https://www.worldpharmatoday.com/uncategorized/smart-inspection-systems-with-hv-leak-detection-technology/</guid>

					<description><![CDATA[<p>The convergence of digital transformation and precision engineering has given rise to a new generation of quality control in pharmaceutical manufacturing. Smart inspection systems with HV leak detection technology utilize advanced sensors and real-time data analytics to identify microscopic structural flaws in sterile packaging with unprecedented accuracy. By automating the detection of leaks that are invisible to the human eye, these intelligent systems significantly enhance the reliability of the manufacturing process, ensuring that every container meets the highest standards of safety and sterility.</p>
The post <a href="https://www.worldpharmatoday.com/production-manufacturing/smart-inspection-systems-with-hv-leak-detection-technology/">Smart Inspection Systems with HV Leak Detection Technology</a> first appeared on <a href="https://www.worldpharmatoday.com">World Pharma Today</a>.]]></description>
		
		
		
			</item>
		<item>
		<title>Clinical Trial Patient Recruitment and Site Selection</title>
		<link>https://www.worldpharmatoday.com/clinical-trails/clinical-trial-patient-recruitment-and-site-selection/</link>
		
		<dc:creator><![CDATA[Yuvraj]]></dc:creator>
		<pubDate>Mon, 30 Mar 2026 11:55:52 +0000</pubDate>
				<category><![CDATA[BioPharma]]></category>
		<category><![CDATA[Clinical Trials]]></category>
		<category><![CDATA[IT & Data Management]]></category>
		<guid isPermaLink="false">https://www.worldpharmatoday.com/uncategorized/clinical-trial-patient-recruitment-and-site-selection/</guid>

					<description><![CDATA[<p>Maximizing the speed and quality of drug development requires a data-driven approach to patient enrollment and site identification, where precision analytics meet operational excellence in the 2026 clinical landscape.</p>
The post <a href="https://www.worldpharmatoday.com/clinical-trails/clinical-trial-patient-recruitment-and-site-selection/">Clinical Trial Patient Recruitment and Site Selection</a> first appeared on <a href="https://www.worldpharmatoday.com">World Pharma Today</a>.]]></description>
		
		
		
			</item>
		<item>
		<title>Roche AI Factory Expansion to Boost Pharma R&#038;D Capacity</title>
		<link>https://www.worldpharmatoday.com/news/roche-ai-factory-expansion-to-boost-pharma-rd-capacity/</link>
		
		<dc:creator><![CDATA[Yuvraj]]></dc:creator>
		<pubDate>Wed, 18 Mar 2026 08:10:47 +0000</pubDate>
				<category><![CDATA[Business & Industry]]></category>
		<category><![CDATA[Drug Research]]></category>
		<category><![CDATA[IT & Data Management]]></category>
		<category><![CDATA[News]]></category>
		<category><![CDATA[Techno Trends]]></category>
		<category><![CDATA[Big Pharma]]></category>
		<category><![CDATA[Pharmaceuticals]]></category>
		<guid isPermaLink="false">https://www.worldpharmatoday.com/uncategorized/roche-ai-factory-expansion-to-boost-pharma-rd-capacity/</guid>

					<description><![CDATA[<p>Swiss drugmaker Roche has expanded its artificial intelligence infrastructure by deploying more than 2,100 NVIDIA chips, strengthening its computational capabilities to accelerate drug and diagnostics development. The move, centred on a large-scale Roche AI factory, reflects the company’s ongoing investment in advanced computing to streamline research and development processes across its global operations. The expansion [&#8230;]</p>
The post <a href="https://www.worldpharmatoday.com/news/roche-ai-factory-expansion-to-boost-pharma-rd-capacity/">Roche AI Factory Expansion to Boost Pharma R&D Capacity</a> first appeared on <a href="https://www.worldpharmatoday.com">World Pharma Today</a>.]]></description>
		
		
		
			</item>
		<item>
		<title>It’s Time for the 3rd Generation of Patient Recruitment</title>
		<link>https://www.worldpharmatoday.com/clinical-trails/its-time-for-the-3rd-generation-of-patient-recruitment/</link>
		
		<dc:creator><![CDATA[Yuvraj]]></dc:creator>
		<pubDate>Wed, 11 Mar 2026 13:28:04 +0000</pubDate>
				<category><![CDATA[Clinical Trials]]></category>
		<category><![CDATA[IT & Data Management]]></category>
		<guid isPermaLink="false">https://www.worldpharmatoday.com/uncategorized/its-time-for-the-3rd-generation-of-patient-recruitment/</guid>

					<description><![CDATA[<p>Key Takeaways 80% of clinical trials experience enrolment delays and massive sunk costs with underperforming sites. Only 4% of US physicians participate in clinical research, leaving 96% of patients inaccessible under other HCPs’ care. Tokenization links Citeline’s proprietary data; specifically, 300+ million claims lives, 245+ million lab lives &#38; 55 million+ EMR patient lives with 1.7+ million HCP national provider identifiers (NPIs). Direct-to-patient traditional advertising recruitment campaigns fail with complex protocol criteria, most commonly in oncology and rare disease protocols. Last-mile operationalization [&#8230;]</p>
The post <a href="https://www.worldpharmatoday.com/clinical-trails/its-time-for-the-3rd-generation-of-patient-recruitment/">It’s Time for the 3rd Generation of Patient Recruitment</a> first appeared on <a href="https://www.worldpharmatoday.com">World Pharma Today</a>.]]></description>
		
		
		
			</item>
		<item>
		<title>Driving Documentation Integrity Through Structured Drug Data</title>
		<link>https://www.worldpharmatoday.com/it-data-management/driving-documentation-integrity-through-structured-drug-data/</link>
		
		<dc:creator><![CDATA[Yuvraj]]></dc:creator>
		<pubDate>Mon, 23 Feb 2026 09:15:43 +0000</pubDate>
				<category><![CDATA[Business & Industry]]></category>
		<category><![CDATA[IT & Data Management]]></category>
		<guid isPermaLink="false">https://www.worldpharmatoday.com/uncategorized/driving-documentation-integrity-through-structured-drug-data/</guid>

					<description><![CDATA[<p>Establishing a robust framework for regulatory success requires moving beyond fragmented information silos toward a unified, digital-first approach. Comprehensive oversight of the pharmaceutical lifecycle depends on the ability to transform raw information into actionable insights, ensuring that every data point contributes to a larger narrative of safety and efficacy. By prioritizing specialized platforms that aggregate and organize complex information, organizations can achieve a level of transparency that satisfies the most stringent global standards while fostering a culture of continuous improvement.</p>
The post <a href="https://www.worldpharmatoday.com/it-data-management/driving-documentation-integrity-through-structured-drug-data/">Driving Documentation Integrity Through Structured Drug Data</a> first appeared on <a href="https://www.worldpharmatoday.com">World Pharma Today</a>.]]></description>
		
		
		
			</item>
		<item>
		<title>Contamination Control with Toxicological Reference Data</title>
		<link>https://www.worldpharmatoday.com/it-data-management/contamination-control-with-toxicological-reference-data/</link>
		
		<dc:creator><![CDATA[Yuvraj]]></dc:creator>
		<pubDate>Mon, 23 Feb 2026 07:59:32 +0000</pubDate>
				<category><![CDATA[Drug Research]]></category>
		<category><![CDATA[IT & Data Management]]></category>
		<guid isPermaLink="false">https://www.worldpharmatoday.com/uncategorized/contamination-control-with-toxicological-reference-data/</guid>

					<description><![CDATA[<p>Centralizing expert-verified toxicological datasets is now a critical requirement for modern pharmaceutical facilities operating under stringent global regulations. By transitioning from generic cleaning limits to precise Health-Based Exposure Limits derived from high-quality platforms, manufacturers ensure that cleaning validation protocols are scientifically sound and audit-ready. This approach integrates rigorous toxicological risk assessment into the broader contamination control strategy, safeguarding patient health while optimizing multi-product manufacturing efficiency and regulatory compliance.</p>
The post <a href="https://www.worldpharmatoday.com/it-data-management/contamination-control-with-toxicological-reference-data/">Contamination Control with Toxicological Reference Data</a> first appeared on <a href="https://www.worldpharmatoday.com">World Pharma Today</a>.]]></description>
		
		
		
			</item>
		<item>
		<title>Aligning Global Clinical Trials with Standardized Drug Data</title>
		<link>https://www.worldpharmatoday.com/articles/aligning-global-clinical-trials-with-standardized-drug-data/</link>
		
		<dc:creator><![CDATA[Yuvraj]]></dc:creator>
		<pubDate>Mon, 23 Feb 2026 06:18:42 +0000</pubDate>
				<category><![CDATA[Articles]]></category>
		<category><![CDATA[Clinical Trials]]></category>
		<category><![CDATA[IT & Data Management]]></category>
		<guid isPermaLink="false">https://www.worldpharmatoday.com/uncategorized/aligning-global-clinical-trials-with-standardized-drug-data/</guid>

					<description><![CDATA[<p>Modern drug development necessitates a shift from fragmented data silos to a unified, intelligence-driven framework. Achieving global regulatory alignment requires a sophisticated approach to trial documentation standards and pharmaceutical regulatory governance, ensuring that clinical trial design remains robust across multiple jurisdictions. By leveraging standardized drug intelligence, sponsors can enhance submission readiness and maintain cross-border compliance, ultimately accelerating the delivery of life-saving therapies to patients worldwide.</p>
The post <a href="https://www.worldpharmatoday.com/articles/aligning-global-clinical-trials-with-standardized-drug-data/">Aligning Global Clinical Trials with Standardized Drug Data</a> first appeared on <a href="https://www.worldpharmatoday.com">World Pharma Today</a>.]]></description>
		
		
		
			</item>
		<item>
		<title>Advancing Quality 4.0 Through Centralized Drug Knowledge </title>
		<link>https://www.worldpharmatoday.com/production-manufacturing/advancing-quality-4-0-through-centralized-drug-knowledge/</link>
		
		<dc:creator><![CDATA[Yuvraj]]></dc:creator>
		<pubDate>Sat, 21 Feb 2026 07:59:02 +0000</pubDate>
				<category><![CDATA[IT & Data Management]]></category>
		<category><![CDATA[Production & Manufacturing]]></category>
		<category><![CDATA[Techno Trends]]></category>
		<category><![CDATA[Drug]]></category>
		<category><![CDATA[Pharmaceuticals]]></category>
		<guid isPermaLink="false">https://www.worldpharmatoday.com/uncategorized/advancing-quality-4-0-through-centralized-drug-knowledge/</guid>

					<description><![CDATA[<p>Implementation of a unified data framework serves as the catalyst for modernizing pharmaceutical production, bridging the gap between legacy processes and intelligent automation. By consolidating disparate data streams into a cohesive repository, organizations achieve unprecedented visibility into critical quality attributes and process parameters. This transformation facilitates proactive risk mitigation and ensures that Good Manufacturing Practices are maintained through high-fidelity insights rather than retrospective analysis, ultimately fostering a culture of continuous improvement and operational excellence.</p>
The post <a href="https://www.worldpharmatoday.com/production-manufacturing/advancing-quality-4-0-through-centralized-drug-knowledge/">Advancing Quality 4.0 Through Centralized Drug Knowledge </a> first appeared on <a href="https://www.worldpharmatoday.com">World Pharma Today</a>.]]></description>
		
		
		
			</item>
		<item>
		<title>Quality Risk Management and the Role of Verified Drug Information</title>
		<link>https://www.worldpharmatoday.com/it-data-management/quality-risk-management-and-the-role-of-verified-drug-information/</link>
		
		<dc:creator><![CDATA[Yuvraj]]></dc:creator>
		<pubDate>Mon, 16 Feb 2026 10:06:03 +0000</pubDate>
				<category><![CDATA[IT & Data Management]]></category>
		<category><![CDATA[Techno Trends]]></category>
		<guid isPermaLink="false">https://www.worldpharmatoday.com/uncategorized/quality-risk-management-and-the-role-of-verified-drug-information/</guid>

					<description><![CDATA[<p>Effective quality risk management in pharmaceutical manufacturing hinges on the availability of verified drug information to ensure GMP compliance and product safety.</p>
The post <a href="https://www.worldpharmatoday.com/it-data-management/quality-risk-management-and-the-role-of-verified-drug-information/">Quality Risk Management and the Role of Verified Drug Information</a> first appeared on <a href="https://www.worldpharmatoday.com">World Pharma Today</a>.]]></description>
		
		
		
			</item>
		<item>
		<title>Improving Pharmacovigilance with Reliable Drug Interaction and Safety Data</title>
		<link>https://www.worldpharmatoday.com/it-data-management/improving-pharmacovigilance-with-reliable-drug-interaction-and-safety-data/</link>
		
		<dc:creator><![CDATA[Yuvraj]]></dc:creator>
		<pubDate>Mon, 16 Feb 2026 09:21:59 +0000</pubDate>
				<category><![CDATA[IT & Data Management]]></category>
		<category><![CDATA[Techno Trends]]></category>
		<guid isPermaLink="false">https://www.worldpharmatoday.com/uncategorized/improving-pharmacovigilance-with-reliable-drug-interaction-and-safety-data/</guid>

					<description><![CDATA[<p>Robust pharmacovigilance strategies rely on the continuous integration of high-quality drug interaction and safety data to protect patient health and ensure regulatory compliance.</p>
The post <a href="https://www.worldpharmatoday.com/it-data-management/improving-pharmacovigilance-with-reliable-drug-interaction-and-safety-data/">Improving Pharmacovigilance with Reliable Drug Interaction and Safety Data</a> first appeared on <a href="https://www.worldpharmatoday.com">World Pharma Today</a>.]]></description>
		
		
		
			</item>
	</channel>
</rss>
